PREDICTORS FOR OFF-THERAPY HBEAG SERO-REVERSION HEPATITIS AND HBEAG-NEGATIVE HEPATITIS IN HBEAG-POSITIVE PATIENTS DISCONTINUE NUC THERAPY ARE DIFFERENT

被引：0
|
作者：
Peng, Chien-Wei [1 ,2 ]
Jeng, Wen-Juei [1 ,2 ]
Chien, Rong-Nan [1 ,2 ,3 ]
Liaw, Yun-Fan [2 ,4 ]
机构：
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Linkou Branch, Liver Res Unit, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp, Liver Res Unit, Linkou, Taiwan
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
797
引用
收藏
页码：489A / 490A
页数：2
相关论文
共 50 条
  • [11] INTERFERON THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC ACTIVE HEPATITIS
    OGAWA, Y
    HORIIKE, N
    ONJI, M
    MICHITAKA, K
    OHTA, Y
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A121 - A121
  • [12] Response-guided peginterferon therapy for hbeag-positive and hbeag-negative chronic hepatitis b using hepatitis b surface antigen levels: A review
    Sonneveld M.J.
    Brouwer W.P.
    Janssen H.L.A.
    Current Hepatology Reports, 2014, 13 (3) : 250 - 255
  • [13] Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation
    Peng, Cheng-Yuan
    Chen, Chih-Bin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Wu, Hong-Dar Isaac
    Jeng, Long-Bin
    HEPATOLOGY INTERNATIONAL, 2011, 5 (01) : 586 - 596
  • [14] Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation
    Cheng-Yuan Peng
    Chih-Bin Chen
    Hsueh-Chou Lai
    Wen-Pang Su
    Po-Heng Chuang
    Hong-Dar Isaac Wu
    Long-Bin Jeng
    Hepatology International, 2011, 5 : 586 - 596
  • [15] Difference of Expression Pattern of Serum Cytokines between HBeAg-positive and HBeAg-negative Chronic Hepatitis B
    He, Dengming
    Li, Maoshi
    Guo, Shimin
    Huang, Hongfei
    Tan, Zhaoxia
    Wang, Yuming
    HEPATOLOGY, 2013, 58 : 416A - 416A
  • [16] Progress in HBeAg-negative chronic hepatitis B therapy
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 (1): : 11 - 11
  • [17] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
    Keshvari, Maryam
    Alavian, Seyed Moayed
    Sharafi, Heidar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)
  • [18] The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore
    Lacey, L. F.
    Gane, E.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (11) : 751 - 766
  • [19] Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients
    Dusheiko, Geoffrey
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (12) : 1439 - 1440
  • [20] Reversion from HBeAg negative to HBeAg positive phenotype after interferon therapy for chronic hepatitis B.
    Kitis, G
    Ilias, A
    Kapetanos, D
    Kiriazis, G
    HEPATOLOGY, 1999, 30 (04) : 601A - 601A
12345